RE:Theralase Cannabinoid/PDC/Radiation PatentEoganacht ... Great digging. Thanks for the update. Cannabioid is still in the plan. That's interesting.
They won't move on the GBM indication though until they get the patent protection on all of the pieces of this treatment.
On some of our other patents, I wonder how much time we usually had between this status:
... 2019-11-28 Application status is Pending and the "granted" one.
That could help us assess how much time we would have to wait on that one.
________________________
Eoganacht - (11/28/2019 5:49:20 PM) Theralase Cannabinoid/PDC/Radiation Patent Google Patents 20190290657 Method for treating conditions associated with hyperproliferating cells comprising combined administration of a cannabinoid receptor agonist and radiation therapy
Abstract
Disclosed is a method for treating a condition associated with hyperproliferating cells, the method including the steps of administering to a subject having the condition a composition including at least one cannabinoid receptor agonist, optionally administering to the subject a photodynamic compound, and administering radiation to the subject in whom the at least one cannabinoid receptor agonist is present so as to treat the condition.
US20190290657A1
United States
-
Inventor: - Roger Dumoulin-White
- Arkady Mandel
- Current Assignee:
- Theralase Technologies Inc
2019 CA US Application US16/365,148 events
2018-03-26 Priority to US201862648334P
2019-03-26 Application filed by Theralase Technologies Inc
2019-03-26 Priority to US16/365,148
2019-03-26 Assigned to THERALASE TECHNOLOGIES, INC.
2019-09-26 Publication of US20190290657A1
2019-11-28 Application status is Pending